Nevertheless, further effort should be made to systematically test the synergy of URB597 with ferroptosis inducers to identify potent inhibitory effects for RCC therapy and the combinational effects of other FAAH inhibitors and ferroptosis inducers. This evidence concerns the gene FAAH and renal cell carcinoma.